Parallel Advisors’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $899 | Sell |
96
-236
| -71% | -$2.21K | ﹤0.01% | 3190 |
|
|
2025
Q1 | $4.08K | Sell |
332
-29
| -8% | -$356 | ﹤0.01% | 2736 |
|
|
2024
Q4 | $4.77K | Hold |
361
| – | – | ﹤0.01% | 2642 |
|
|
2024
Q3 | $6.95K | Hold |
361
| – | – | ﹤0.01% | 2501 |
|
|
2024
Q2 | $7.41K | Sell |
361
-124
| -26% | -$2.55K | ﹤0.01% | 2401 |
|
|
2024
Q1 | $11.5K | Buy |
485
+124
| +34% | +$2.95K | ﹤0.01% | 2243 |
|
|
2023
Q4 | $7.8K | Sell |
361
-125
| -26% | -$2.7K | ﹤0.01% | 2379 |
|
|
2023
Q3 | $7.06K | Buy |
+486
| New | +$7.06K | ﹤0.01% | 2356 |
|
|
2022
Q4 | – | Sell |
-20
| Closed | – | – | 3514 |
|
|
2022
Q3 | $0 | Buy |
20
+11
| +122% | – | ﹤0.01% | 3471 |
|
|
2022
Q2 | $0 | Buy |
+9
| New | – | ﹤0.01% | 3329 |
|
|
2022
Q1 | – | Sell |
-13
| Closed | – | – | 3258 |
|
|
2021
Q4 | $0 | Buy |
+13
| New | – | ﹤0.01% | 3286 |
|